Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Yaswen

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Reinforcing targeted therapeutics with phenotypic stability factorsPaul Yaswen
Cell|January 27, 2007
Oncogene-induced senescence pathways weave an intricate tapestryPaul Yaswen, Judith Campisi
Cell Cycle (Georgetown, Tex.)|May 31, 2007
Soothing the watchman: telomerase reduces the p53-dependent cellular stress responseAlain Beliveau, Paul Yaswen
Aging Cell|July 25, 2009
Aging and cancer cell biology, 2009Judith Campisi, Paul Yaswen
The International Journal of Biochemistry & Cell Biology|August 30, 2002
Molecular changes accompanying senescence and immortalization of cultured human mammary epithelial cellsPaul Yaswen, Martha R Stampfer
Breast Cancer Research : BCR|June 4, 2011
Who is in the driver's seat in 8p12 amplifications? ZNF703 in luminal B breast tumorsAlexey V Bazarov, Paul Yaswen
Cancer Letters|May 22, 2003
Human epithelial cell immortalization as a step in carcinogenesisMartha R Stampfer, Paul Yaswen
Nature Communications|April 22, 2015
Modelling breast cancer requires identification and correction of a critical cell lineage-dependent transduction biasWilliam C Hines, Paul Yaswen, Mina J Bissell
Plos One|March 23, 2010
BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomasWilliam C Hines, Alexey V Bazarov, Rituparna Mukhopadhyay, et al.
Molecular Cancer Therapeutics|October 7, 2015
A TORC2-Akt Feed-Forward Topology Underlies HER3 Resiliency in HER2-Amplified CancersDhara N Amin, Deepika Ahuja, Paul Yaswen, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Reinforcing targeted therapeutics with phenotypic stability factorsPaul Yaswen
Cell|January 27, 2007
Oncogene-induced senescence pathways weave an intricate tapestryPaul Yaswen, Judith Campisi
Cell Cycle (Georgetown, Tex.)|May 31, 2007
Soothing the watchman: telomerase reduces the p53-dependent cellular stress responseAlain Beliveau, Paul Yaswen
Aging Cell|July 25, 2009
Aging and cancer cell biology, 2009Judith Campisi, Paul Yaswen
The International Journal of Biochemistry & Cell Biology|August 30, 2002
Molecular changes accompanying senescence and immortalization of cultured human mammary epithelial cellsPaul Yaswen, Martha R Stampfer
Breast Cancer Research : BCR|June 4, 2011
Who is in the driver's seat in 8p12 amplifications? ZNF703 in luminal B breast tumorsAlexey V Bazarov, Paul Yaswen
Cancer Letters|May 22, 2003
Human epithelial cell immortalization as a step in carcinogenesisMartha R Stampfer, Paul Yaswen
Nature Communications|April 22, 2015
Modelling breast cancer requires identification and correction of a critical cell lineage-dependent transduction biasWilliam C Hines, Paul Yaswen, Mina J Bissell
Plos One|March 23, 2010
BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomasWilliam C Hines, Alexey V Bazarov, Rituparna Mukhopadhyay, et al.
Molecular Cancer Therapeutics|October 7, 2015
A TORC2-Akt Feed-Forward Topology Underlies HER3 Resiliency in HER2-Amplified CancersDhara N Amin, Deepika Ahuja, Paul Yaswen, et al.
Pageof 5